These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5648425)

  • 1. The role of the adrenergic system in the mechanism of action of Bordetella pertussis vaccine.
    Arora S; Sanyal RK
    Int Arch Allergy Appl Immunol; 1968; 33(3):299-305. PubMed ID: 5648425
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of a cardio-selective beta-adrenergic blocking agent on the heart and coronary circulation.
    Ross G; Jorgensen CR
    Cardiovasc Res; 1970 Apr; 4(2):148-53. PubMed ID: 4392942
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacology of amiodarone, and anti-anginal drug with a new biological profile.
    Charlier R; Deltour G; Baudine A; Chaillet F
    Arzneimittelforschung; 1968 Nov; 18(11):1408-17. PubMed ID: 5755904
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective blockade of adrenoceptive beta receptors in the heart.
    Dunlop D; Shanks RG
    Br J Pharmacol Chemother; 1968 Jan; 32(1):201-18. PubMed ID: 4384337
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenergic receptors in the female canine urethra.
    Raz S; Caine M
    Invest Urol; 1972 Jan; 9(4):319-23. PubMed ID: 4333705
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
    Brunner H; Hedwall PR; Meier M
    Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
    [No Abstract]   [Full Text] [Related]  

  • 7. Desoxyisoprenaline: an adrenoceptor stimulating and blocking agent.
    Maengwyn-Davies GD; Fleisch JH; Pruss TP
    J Pharm Pharmacol; 1972 Apr; 24(4):295-301. PubMed ID: 4402837
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 9. Structure-activity relationships in the adrenergic-blocking agents.
    Ghouri MS; Haley TJ
    J Pharm Sci; 1969 May; 58(5):511-38. PubMed ID: 4389589
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral effectiveness of beta adrenergic antagonists in preventing epinephrine-induced metabolic responses.
    Brown JH; Riggilo DA; Dungan KW
    J Pharmacol Exp Ther; 1968 Sep; 163(1):25-35. PubMed ID: 5673713
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of epinephrine, norepinephrine and isoproterenol against challenge in Bordetella pertussis-treated and beta-adrenergic blocked mice.
    Bergman RK; Munoz J
    Life Sci II; 1971 May; 10(10):561-8. PubMed ID: 4397558
    [No Abstract]   [Full Text] [Related]  

  • 12. The pharmacological actions of butidrine. A comparative study of this new beta-adrenergic receptor antagonist and its four stereoisomers.
    Ferrini R; Miragoli G; Croce G
    Arzneimittelforschung; 1968 Jul; 18(7):829-33. PubMed ID: 4387812
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT; Gluckman MI
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular and lipid mobilizing effects of tetrahydroisoquinoline.
    Tóth E; Fassina G; Soncin ES
    Arch Int Pharmacodyn Ther; 1967 Oct; 169(2):375-83. PubMed ID: 6064567
    [No Abstract]   [Full Text] [Related]  

  • 15. Opposite effects of amiodarone and -blocking agents on cardiac function under adrenergic stimulation.
    Charlier R; Delaunois G; Bauthier J
    Arzneimittelforschung; 1972 Mar; 22(3):545-52. PubMed ID: 4402603
    [No Abstract]   [Full Text] [Related]  

  • 16. Some peripheral pharmacological characteristics of benzoctamine.
    Jaques R; Rüegg M
    Pharmacology; 1971; 6(2):89-98. PubMed ID: 4400350
    [No Abstract]   [Full Text] [Related]  

  • 17. Adrenergic mechanisms in cardiac glycogen metabolism.
    Mayer SE; Williams BJ; Smith JM
    Ann N Y Acad Sci; 1967 Feb; 139(3):686-702. PubMed ID: 4382728
    [No Abstract]   [Full Text] [Related]  

  • 18. A new potentially antianginal benzofuran with an amiodarone-like pharmacological profile.
    Charlier R; Bauthier J
    Arzneimittelforschung; 1973 Sep; 23(9):1305-11. PubMed ID: 4801226
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action and mechanism of action of catecholamines and their derivatives].
    Ariëns EJ
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):118-41. PubMed ID: 4385328
    [No Abstract]   [Full Text] [Related]  

  • 20. [Differentiation of adrenergic receptors and their variable importance in drug therapy].
    Hapke HJ
    Dtsch Tierarztl Wochenschr (1946); 1969 Nov; 76(22):617-21. PubMed ID: 4922890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.